LB PharmaceuticalsCommon Stock Other Current Liabilities

The latest other current liabilities for LBRX is $3.1M as of March 2026. Investors often review this figure alongside LB PharmaceuticalsCommon Stock's historical trend and sector peers before judging valuation or financial health.

A other current liabilities figure of $3.1M for LBRX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting LBRX's other current liabilities ($3.1M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack LB PharmaceuticalsCommon Stock's other current liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.